The fatty layer around cells is secretly controlling one of biology’s most important switches
Cells are wrapped in a thin membrane made mostly of fat. For decades, that membrane was treated as a passive scaffold.
The epidermal growth factor receptor — EGFR — is one of the most studied proteins in biology. It sits in the outer wall of cells, detects growth signals from the surrounding environment, and relays those signals inward to influence cell behaviour. When EGFR malfunctions, cells can proliferate uncontrollably, which is why it has been a drug target in cancer treatment for decades. Despite that attention, the precise mechanics of how EGFR is switched on and off have remained incompletely understood.
A new study published in eLife shows that the cell membrane — the lipid-rich outer boundary of every cell — is not a passive housing for EGFR but an active regulator of its behaviour. Depending on the specific composition of the membrane — which fats are present, how much cholesterol is embedded, how they are arranged — the receptor can be suppressed or activated. The membrane functions as a tuning mechanism that sets the receptor’s baseline sensitivity before any external signal arrives.
What this means for cancer drug resistance
Existing EGFR-targeting drugs — used in lung cancer, colorectal cancer, and other malignancies — work by blocking the receptor directly. But if the membrane controls part of EGFR’s activity independently of the receptor’s own structure, then the membrane represents a second point of intervention. Drugs or strategies that alter membrane composition or disrupt the membrane-receptor interface could offer an alternative route — one that might circumvent resistance mechanisms that currently limit the effectiveness of EGFR inhibitors.
The relevance extends beyond cancer. Cell membrane composition changes with age: the ratio of different lipids shifts, cholesterol distribution becomes less uniform, and the physical properties of the membrane alter. If the membrane helps set the gain on growth signalling, then age-related changes in membrane composition could contribute to the dysregulated cell signalling that characterises ageing tissue — not through mutations in receptors or signalling proteins, but through the physical environment those proteins inhabit.
Engineering clarity out of biological complexity
Studying membrane effects on specific proteins in living cells is technically difficult because real membranes contain hundreds of different molecular species in constant motion. The researchers addressed this by using synthetic membranes with controlled compositions, allowing them to isolate the contribution of specific lipid molecules to EGFR behaviour — a methodologically elegant approach that trades some biological realism for mechanistic precision.
The broader implication is conceptual: a receptor’s function is not fully encoded in its own structure. The environment it sits in matters. How widely that principle applies across the hundreds of other receptors embedded in cell membranes is a question this study raises without answering.